Hermes Medical Solutions AB is a corporate office based in Stockholm, specializing in nuclear medicine and molecular imaging. The company is recognized as an industry leader, providing vendor-neutral software solutions that cater to the specific needs of healthcare providers. Their flagship product, Hermia Molecular Imaging Software, is designed to enhance the efficiency of test readings, facilitating improved diagnostic processes.
The company has achieved significant regulatory milestones, including recent FDA clearance for the Centiloid scale and 510(K) FDA clearance for Hermia Voxel Dosimetry. These approvals underscore the company's commitment to delivering reliable and innovative solutions in the field of nuclear medicine. Additionally, Hermes Medical Solutions AB is dedicated to advancing education in this specialized area through initiatives such as the Hermia Academy, which focuses on training and knowledge dissemination for healthcare professionals.